Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an update.
NeuroScientific Biopharmaceuticals Ltd has announced a change in its registered and principal office address, now located at Level 4, 216 St Georges Terrace, Perth, Western Australia 6000. This operational update includes a change in the company’s contact number, reflecting administrative adjustments to streamline operations.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Ltd operates in the biopharmaceutical industry, focusing on developing neurological drugs and therapies. The company aims to address unmet medical needs in neurological disorders through innovative treatments.
YTD Price Performance: 30.0%
Average Trading Volume: 133,789
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.64M
For a thorough assessment of NSB stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue